• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

1-Piperazinecarboximidamide, 4-cyclohexyl-, hydriodide (1:1) (CAS No. 849776-37-0)

1-Piperazinecarboximidamide, 4-cyclohexyl-, hydriodide (1:1) (CAS No. 849776-37-0) is a unique compound with significant potential in the field of medicinal chemistry and pharmaceutical research. This compound, also known as 4-Cyclohexylpiperazine-1-carboximidamide hydroiodide, is a derivative of piperazine and cyclohexyl groups, making it a valuable candidate for various therapeutic applications.

The chemical structure of 1-Piperazinecarboximidamide, 4-cyclohexyl-, hydriodide (1:1) consists of a piperazine ring linked to a cyclohexyl group and an imidamide functional group. The presence of the hydroiodide salt enhances its solubility and stability, making it suitable for both in vitro and in vivo studies. The molecular formula is C₁₃H₂₃N₄I, with a molecular weight of approximately 308.25 g/mol.

Recent research has highlighted the potential of 4-Cyclohexylpiperazine-1-carboximidamide hydroiodide in various biological systems. Studies have shown that this compound exhibits potent anti-inflammatory and antioxidant properties, which are crucial for the treatment of chronic diseases such as arthritis and neurodegenerative disorders. Additionally, its ability to modulate specific receptors and signaling pathways has been explored in the context of cancer therapy.

In the realm of pharmaceutical development, 1-Piperazinecarboximidamide, 4-cyclohexyl-, hydriodide (1:1) has shown promise as a lead compound for drug discovery. Its unique chemical structure allows for easy modification and optimization, making it an attractive starting point for the synthesis of more potent and selective analogs. Researchers have been particularly interested in its potential to target G protein-coupled receptors (GPCRs) and ion channels, which are key players in many physiological processes.

The synthesis of 4-Cyclohexylpiperazine-1-carboximidamide hydroiodide involves several well-established chemical reactions. The initial step typically involves the formation of the piperazine ring, followed by the introduction of the cyclohexyl group and the imidamide functional group. The final step involves the addition of hydroiodic acid to form the hydroiodide salt. This synthetic route is scalable and can be adapted for large-scale production, ensuring a consistent supply for both research and commercial purposes.

From a pharmacological perspective, 1-Piperazinecarboximidamide, 4-cyclohexyl-, hydriodide (1:1) has demonstrated favorable pharmacokinetic properties. It exhibits good oral bioavailability and a reasonable half-life, making it suitable for chronic dosing regimens. Preclinical studies have also shown that it has low toxicity and minimal side effects, which are essential considerations for drug development.

In conclusion, 4-Cyclohexylpiperazine-1-carboximidamide hydroiodide (CAS No. 849776-37-0) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure, combined with its biological activities and favorable pharmacological properties, makes it an exciting candidate for further investigation and development. As research in this area continues to advance, it is likely that new therapeutic uses will be discovered, further solidifying its importance in the field.

• 100862-81-5(2,6-dimethylpiperidine-1-carboximidamide)
• 480999-06-2(GUANIDINE, N'-BUTYL-N,N-DICYCLOHEXYL-)
• 849776-34-7([1,4'-Bipiperidine]-1'-carboximidamide,hydriodide (1:2))
• 139256-80-7(1-Piperazinecarboximidamide, 4-cyclopropyl-)
• 759427-47-9(1-Piperazinecarboximidamide,3,5-dimethyl-,cis-(9CI))
• 138370-95-3(Guanidine, N,N-dibutyl-N',N'-dicyclohexyl-)
• 805190-66-3(Guanidine,[2-(3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)ethyl]-(9CI))
• 92564-60-8(1-Piperazinecarboximidamide,2,5-dimethyl-)
• 791748-40-8(1-Pyrrolidinecarboximidamide,2-(aminomethyl)-)
• 477482-04-5